4
Changes in Ownership
Vivos Therapeutics, Inc. Filed Acc 0001493152-21-023354
Chief Executive Officer bought 5,000 shares at $4.31 ($21,550)
From the SEC's structured data for this filing
Trades in this filing
Huntsman Ronald Kirk · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-21 | Purchase : show line 1 in the form | +5,000 | $4.31 | $21,550 | 15,500 | D |
| Open-market purchases · 5,000 sh · avg $4.31 · $21,550 | ||||||
Loading xslF345X03/ownership.xml…